Therapeutic charm of quercetin and its derivatives: a review of research and patents

Papers of special note have been highlighted as: • of interest; •• of considerable interest

References

• 1 Brito AF, Ribeiro M, Abrantes AM et al. Quercetin in cancer treatment, alone or in combination with conventional therapeutics? Curr. Med. Chem. 22, 3025–3039 (2015).
  Medline CASGoogle Scholar
• 2 Lu MF, Xiao ZT, Zhang HY. Where do health benefits of flavonoids come from? Insights from flavonoid targets and their evolutionary history. Biochem. Biophys. Res. Commun. 434, 701–704 (2013).
  Medline CASGoogle Scholar
• 3 Nam JS, Sharma AR, Nguyen LT, Chakraborty C, Sharma G, Lee SS. Application of bioactive quercetin in oncotherapy: from nutrition to nanomedicine. Molecules 21, E108 (2016).
  MedlineGoogle Scholar
• 4 Romano B, Pagano E, Montanaro V, Fortunato AL, Milic N, Borrelli F. Novel insights into the pharmacology of flavonoids. Phytother. Res. 27, 1588–1596 (2013).
  Medline CASGoogle Scholar
• 5 Russo M, Spagnuolo C, Tedesco I, Bilotto S, Russo GL. The flavonoid quercetin in disease prevention and therapy: facts and fancies. Biochem. Pharmacol. 83, 6–15 (2012).
  Medline CASGoogle Scholar
• 6 Sak K. Cytotoxicity of dietary flavonoids on different human cancer types. Pharmacogn. Rev. 8, 122–146 (2014).
  Medline CASGoogle Scholar
• 7 Kelly GS. Quercetin Monograph. Altern. Med. Rev. 16, 172–194 (2011).
  MedlineGoogle Scholar
• 8 Li Y, Yao J, Han C et al. Quercetin, inflammation and immunity. Nutrients 8, 167 (2016).
  MedlineGoogle Scholar
• 9 D'Andrea G. Quercetin: a flavonol with multifaceted therapeutic applications? Fitoterapia 106, 256–271 (2015).
  MedlineGoogle Scholar
• 10 Rani N, Velan LP, Vijaykumar S, Arunachalam A. An insight into the potentially old-wonder molecule-quercetin: the perspectives in foresee. Chin. J. Integr. (2015).
  MedlineGoogle Scholar
• 11 Miles SL, McFarland M, Niles RM. Molecular and physiological actions of quercetin: need for clinical trials to assess its benefits in human disease. Nutr. Rev. 72, 720–734 (2014).
  MedlineGoogle Scholar
• 12 Sak K. Site-specific anticancer effects of dietary flavonoid quercetin. Nutr. Cancer 66, 177–193 (2014).
  Medline CASGoogle Scholar
• 13 Hrelia S, Angeloni C. Chapter13-quercetin and its metabolites in heart health. In: Bioactive Food As Dietary Interventions For Cardiovascular Disease. Watson RR, Preedy VR (Eds). Academic Press, London, UK, 217–225 (2013).
  Google Scholar
• 14 Talapatra SK, Talapatra B. Chapter 14, Polyketide pathway. Biosynthesis of diverse classes of aromatic compounds. In: Chemistry Of Plant Natural Products: Stereochemistry, Conformation, Synthesis, Biology, And Medicine (1st Edition). Springer, New York, 689–692 (2015).
  Google Scholar
• 15 Winkel-Shirley B. Flavonoid biosynthesis. A colorful model for genetics, biochemistry, cell biology, and biotechnology. Plant Physiol. 126(2), 485–493 (2001).
  Medline CASGoogle Scholar
• 16 Kostanecki ST, Lampe V, Tambor J. Synthese des quercetins. Eur. J. Inorg. Chem. 37(2), 1402–1405 (1904).
  Google Scholar
• 17 Gutzke M, Fox D, Ciereszko L, Wender S. Synthesis of quercetin-2-C14. J. Org. Chem. 22(10), 1271–1272 (1957).
  CASGoogle Scholar
• 18 MuraKami T, Tanaka N. Occurrence, structure and taxonomic implications of fern constituents. In: Progress in the Chemistry of Organic Natural Products (Vol. 54). Springer, New York (NY), 23–29 (1988).
  Google Scholar
• 19 Allan J, Robinson R. CCCIX-A new synthesis of fisetin and of quercetin. J. Chem. Soc. 129, 2334–2336 (1926).
  Google Scholar
• 20 Kashyap D, Sharma A, Mukherjee TK, Tuli HS, Sak K. Quercetin and ursolic acid: dietary moieties with promising role in tumor cell cycle arrest. Austin Oncol. 1(2), 1010 (2016). •• A review article summarizing various cell cycle inhibitory mechanisms of quercetin (Quer).
  Google Scholar
• 21 Du Y, Wei G, Linhardt RJ. Total synthesis of quercetin 3-Sophorotrioside. J. Org. Chem. 69(6), 2206–2209 (2004).
  Medline CASGoogle Scholar
• 22 Ren X, Shen LI, Muraoka O, Cheng M. Synthesis of quercetin 3-O-[6″-O-(trans-p-Coumaroyl)]-β-D-Glucopyranoside. J. Carbohydr. Chem. 30(3), 119–131 (2011).
  CASGoogle Scholar
• 23 Veverka M, Dubaj T, Gallovic J et al. Cocrystals of quercetin: synthesis, characterization, and screeningof biological activity. Monatsh. Chem. 146, 99 (2015).
  CASGoogle Scholar
• 24 Smith AJ, Kavuru P, Wojtas L, Zaworotko J, Shytle RD. Cocrystals of quercetin with improved solubility and oral bioavailability. Mol. Pharm. 8(5), 1867–1876 (2011).
  Medline CASGoogle Scholar
• 25 Delgado L, Fernandes I, Gonzales-Manzano S, de Freitas V, Mateus N, Santos-Buelga C. Anti-proliferative effects of quercetin and catechin metabolits. Food Funct. 5, 797–803 (2014).
  Medline CASGoogle Scholar
• 26 Kawai Y. β-Glucuronidase activity and mitochondrial dysfunction: the sites where flavonoid glucuronides act as anti-inflammatory agents. J. Clin. Biochem. Nutr. 54, 145–150 (2014).
  Medline CASGoogle Scholar
• 27 Men K, Duan X, Wei XW et al. Nanoparticle-delivered quercetin for cancer therapy. Anticancer Agents Med. Chem. 14, 826–832 (2014).
  Medline CASGoogle Scholar
• 28 Araujo KCF, de M B Costa EM, Pazini F, Valadaresb MC, de Oliveira V. Bioconversion of quercetin and rutin and the cytotoxicity activities of the transformed products. Food Chem. Toxicol. 51, 93–96 (2013).
  Medline CASGoogle Scholar
• 29 Leonarduzzi G, Testa G, Sottero B, Gamba P, Poli G. Design and development of nanovehicles-based delivery systems for preventive or therapeutic supplementation with flavonoids. Curr. Med. Chem. 17, 74–95 (2010).
  Medline CASGoogle Scholar
• 30 Donnini S, Finett F, Lusini L et al. Divergent effects of quercetin conjugates on angiogenesis. Br. J. Nutr. 95, 1016–1023 (2006).
  Medline CASGoogle Scholar
• 31 Roubalova L, Purchatova K, Papouskova B et al. Sulfation modulates the cell uptake, antiradical activity and biological effects of flavonoids in vitro: An examination of quercetin, isoquercetirin and taxifolin. Bioorg. Med. Chem. 23, 5402–5409 (2015).
  Medline CASGoogle Scholar
• 32 Tribolo S, Lodi F, Connor C et al. Comparative effects of quercetin and its predominants human metabolites on adhesion molecule expression in activated human vascular endothelial cells. Atherosclerosis 197, 50–56 (2008).
  Medline CASGoogle Scholar
• 33 Yeh SL, Lin YC, Lin YL, Li CC, Chuang CH. Comparing the metabolism of quercetin in rats, mice and gerbils. Eur. J. Nutr. 55, 413–422 (2016).
  Medline CASGoogle Scholar
• 34 Egert S, Wolffram S, Bosy-Westphal A et al. Daily quercetin supplementation dose-dependently increases plasma quercetin concentrations in healthy humans. J. Nutr. 138, 1615–1621 (2008).
  Medline CASGoogle Scholar
• 35 Yeh SL, Yeh CL, Chan ST, Chuang CH. Plasma rich in quercetin metabolites induces G2/M arrest by upregulating PPAR-γ expression in human A549 lung cancer cells. Planta Med. 77, 992–998 (2011).
  Medline CASGoogle Scholar
• 36 Dabur Pharma Limited: US 20110034413 (2011).
  Google Scholar
• 37 Konkuk Univ. Ind. Coop. Corp.: KR20110064006A (2011). • Synthesized Quer derivatives shown good anticancer activity.
  Google Scholar
• 38 UHA Mikakuto Co Ltd.: JP2013227231A (2013).
  Google Scholar
• 39 UHA Mikakuto Co Ltd.: JP2013245207A (2013).
  Google Scholar
• 40 Zhengzhou University: CN 103214445A (2013). • Quer amide derivatives having significant pharmacological activities and minimal side effects.
  Google Scholar
• 41 Zhengzhou University: CN103239437B (2014). •• Showing great cytotoxic effect of Quer derivatives than 5-FU.
  Google Scholar
• 42 Quercegen Pharmaceuticals LLC.: US20150366838 A1 (2015).
  Google Scholar
• 43 UHA Mikakuto Co Ltd.: JP2015086186 A (2015).
  Google Scholar
• 44 Dalian Medical University. CN103467426 B (2015). • Studied enhanced anticancer activity of Quer by introducing hydrocarbon group.
  Google Scholar
• 45 Nanjing Huitelai Pharmaceutical Co Ltd. CN104557891 A (2015).
  Google Scholar
• 46 UHA Mikakuto Co Ltd. JP5888121B2 (2016).
  Google Scholar
• 47 UHA Mikakuto Co Ltd. JP5891970B2 (2016). • Significant antiproliferative of Quer derivative on NRK-49F.
  Google Scholar
• 48 Korres S.A. Natural Products. US20110034427A1 (2011).
  Google Scholar
• 49 BEL/NOVAMANN International SRO.: EP2468741 A1 (2012).
  Google Scholar
• 50 Ustav exp. farmakologie a toxikologie SAV.: WO2013130020A1 (2013).
  Google Scholar
• 51 Quercegen Pharmaceuticals LLC.: US20140206695A1 (2014).
  Google Scholar
• 52 Univ. Tianjin Science & Tech.: CN104592331 A (2015). •• Superior free radical scavenging ability of Quer derivative.
  Google Scholar
• 53 Univ. Konkuk Ind. Coop. Corp. KR20120095534 A (2012).
  Google Scholar
• 54 Quercegen Pharmaceuticals LLC. US20130129680A1 (2013).
  Google Scholar
• 55 Uni. Malaya. Bakar SA.: US20160000749A1 (2016).
  Google Scholar
• 56 Fudan University: CN102993148 A (2015).
  Google Scholar
• 57 UHA Mikakuto Co Ltd. JP2013227235A (2013).
  Google Scholar
• 58 Okamoto Plant Breeding Co. Ltd. WO2012111795A1 (2012).
  Google Scholar
• 59 Shandong University of Technology: CN104274455 A (2015).
  Google Scholar
• 60 Univ. Fukuoka, Fukuoka Prefecture, Nutrition for Life Ass. Co. Ltd.: WO2015025816 A1 (2015).
  Google Scholar
• 61 Nanjing Ruiying Runze Biopharmaceutical Technology Co. INC.: WO 2015169121 A1 (2015).
  Google Scholar
• 62 Futamura Yoshihiro.: JP2016060718 A (2016).
  Google Scholar
• 63 Quercegen Pharmaceuticals LLC.: US20130095095A1 (2013).
  Google Scholar
• 64 Nanchang University: CN103709131 A (2014).
  Google Scholar
• 65 Weifang Medical University: CN103520139 B (2015).
  Google Scholar
• 66 Ferry DR, Smith A, Malkhandi J et al. Phase I clinical trial of the flavonoid quercetin: pharmacokinetics and evidence for in vivo tyrosine kinase inhibition. Clin. Cancer Res. 2(4), 659–668 (1996).
  Medline CASGoogle Scholar
• 67 Askari G, Ghiasvand R, Feizi A, Ghanadian SM, Karimian J. The effect of quercetin supplementation on selected markers of inflammation and oxidative stress. J. Res. Med. Sci. 17(7), 637–641 (2012).
  MedlineGoogle Scholar
• 68 Clinical trials database: NCT02989129. https://clinicaltrials.gov/ct2/show/NCT02989129.
  Google Scholar